M M Estabrook
Overview
Explore the profile of M M Estabrook including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Estabrook M, Zhou D, Apicella M
Infect Immun
. 1998 Mar;
66(3):1028-36.
PMID: 9488392
Although complement-mediated bactericidal activity in serum has long been known to be very important in host defense against Neisseria meningitidis, recent studies have shown that opsonic phagocytosis by neutrophils is...
2.
Estabrook M, Griffiss J, Jarvis G
Infect Immun
. 1997 Nov;
65(11):4436-44.
PMID: 9353017
Exogenous sialylation of gonococcal lipooligosaccharide causes resistance to serum bactericidal activity. The aim of this study was to determine how lipooligosaccharide sialylation affects the serum sensitivities of group C Neisseria...
3.
Woods C, Koeuth T, Estabrook M, Lupski J
J Infect Dis
. 1996 Oct;
174(4):760-7.
PMID: 8843214
Outbreaks of invasive disease caused by Neisseria meningitidis have increased in the United States in the 1990s. Repetitive element-based polymerase chain reaction (rep-PCR), a recently developed genotyping method, was used...
4.
Hamadeh R, Estabrook M, Zhou P, Jarvis G, Griffiss J
Infect Immun
. 1995 Dec;
63(12):4900-6.
PMID: 7591153
alpha 1,3-Galactosyl antibodies (anti-Gal) are ubiquitous natural human serum and secretory polyclonal antibodies that bind to terminal galactose-alpha 1,3-galactose (alpha-galactosyl) residues. Serum immunoglobulin G (IgG) anti-Gal can block alternative complement...
5.
Estabrook M, Baker C, Griffiss J
J Infect Dis
. 1993 Apr;
167(4):966-70.
PMID: 7680702
A human inhibition monoclonal ELISA (HIMELISA) was used to investigate the immune response of infants and children to meningococcal lipooligosaccharide (LOS). Convalescence from disseminated meningococcal disease significantly increased the inhibition...
6.
Estabrook M, Christopher N, Griffiss J, Baker C, Mandrell R
J Infect Dis
. 1992 Nov;
166(5):1079-88.
PMID: 1402019
This study describes the association of lipooligosaccharide (LOS) and capsule sialylation with the survival of 25 serogroup C meningococcal strains in phagocytosis assays. Eleven strains isolated from children were of...
7.
Estabrook M, Mandrell R, Apicella M, Griffiss J
Infect Immun
. 1990 Jul;
58(7):2204-13.
PMID: 1694820
We developed a human inhibition monoclonal enzyme-linked immunosorbent assay (HIMELISA) to investigate the human immune response to the lipooligosaccharides (LOS) of Neisseria meningitidis. Monoclonal antibodies (MAb) were used to define...
8.
Hack M, Estabrook M, Robertson S
Early Hum Dev
. 1985 Jul;
11(2):133-40.
PMID: 4029050
We studied the ontogeny and temporal organization of non-nutritive sucking during active sleep in 6 healthy preterm infants (mean birthweight 1.1 kg (range 0.8-1.3 kg) gestational age 28.6 weeks (range...